Pulmatrix Statistics
Total Valuation
Pulmatrix has a market cap or net worth of $26.15 million. The enterprise value is $14.89 million.
Important Dates
The next estimated earnings date is Thursday, March 27, 2025, before market open.
| Earnings Date | Mar 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Pulmatrix has 3.65 million shares outstanding. The number of shares has increased by 0.09% in one year.
| Current Share Class | 3.65M |
| Shares Outstanding | 3.65M |
| Shares Change (YoY) | +0.09% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 7.24% |
| Float | 3.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.57 |
| Forward PS | n/a |
| PB Ratio | 2.35 |
| P/TBV Ratio | 2.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.40
| Current Ratio | 19.40 |
| Quick Ratio | 18.31 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -62.70% and return on invested capital (ROIC) is -23.52%.
| Return on Equity (ROE) | -62.70% |
| Return on Assets (ROA) | -19.21% |
| Return on Invested Capital (ROIC) | -23.52% |
| Return on Capital Employed (ROCE) | -67.93% |
| Revenue Per Employee | $454,773 |
| Profits Per Employee | -$438,909 |
| Employee Count | 22 |
| Asset Turnover | 0.41 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +294.94% in the last 52 weeks. The beta is 1.61, so Pulmatrix's price volatility has been higher than the market average.
| Beta (5Y) | 1.61 |
| 52-Week Price Change | +294.94% |
| 50-Day Moving Average | 6.40 |
| 200-Day Moving Average | 3.21 |
| Relative Strength Index (RSI) | 54.79 |
| Average Volume (20 Days) | 33,084 |
Short Selling Information
The latest short interest is 47,656, so 1.30% of the outstanding shares have been sold short.
| Short Interest | 47,656 |
| Short Previous Month | 39,484 |
| Short % of Shares Out | 1.30% |
| Short % of Float | 1.30% |
| Short Ratio (days to cover) | 0.75 |
Income Statement
In the last 12 months, Pulmatrix had revenue of $10.01 million and -$9.66 million in losses. Loss per share was -$2.64.
| Revenue | 10.01M |
| Gross Profit | -671,000 |
| Operating Income | -7.42M |
| Pretax Income | -8.85M |
| Net Income | -9.66M |
| EBITDA | -7.27M |
| EBIT | -7.42M |
| Loss Per Share | -$2.64 |
Full Income StatementBalance Sheet
| Cash & Cash Equivalents | 10.78M |
| Total Debt | n/a |
| Net Cash | 10.78M |
| Net Cash Per Share | $2.95 |
| Equity (Book Value) | 10.92M |
| Book Value Per Share | 2.99 |
| Working Capital | 10.86M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$11.47 million and capital expenditures -$703,000, giving a free cash flow of -$12.17 million.
| Operating Cash Flow | -11.47M |
| Capital Expenditures | -703,000 |
| Free Cash Flow | -12.17M |
| FCF Per Share | -$3.33 |
Full Cash Flow StatementMargins
Gross margin is -6.71%, with operating and profit margins of -74.14% and -96.51%.
| Gross Margin | -6.71% |
| Operating Margin | -74.14% |
| Pretax Margin | -96.51% |
| Profit Margin | -96.51% |
| EBITDA Margin | -72.70% |
| EBIT Margin | -74.14% |
| FCF Margin | n/a |